Experimental inhibitor reduces cell death in models of life-threatening skin reactions
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Oct 24, 2025
0
15









